These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21077714)

  • 1. An elementary approach to modeling drug resistance in cancer.
    Tomasetti C; Levy D
    Math Biosci Eng; 2010 Oct; 7(4):905-18. PubMed ID: 21077714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An elementary mathematical modeling of drug resistance in cancer.
    Bao K
    Math Biosci Eng; 2020 Dec; 18(1):339-353. PubMed ID: 33525095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic modeling of drug resistance in cancer.
    Komarova N
    J Theor Biol; 2006 Apr; 239(3):351-66. PubMed ID: 16194548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model.
    Chen JH; Kuo YH; Luh HP
    Math Biosci; 2013 Oct; 245(2):282-98. PubMed ID: 23927854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
    Cassidy T; Nichol D; Robertson-Tessi M; Craig M; Anderson ARA
    PLoS Comput Biol; 2021 Aug; 17(8):e1009348. PubMed ID: 34460809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.
    Greene JM; Gevertz JL; Sontag ED
    JCO Clin Cancer Inform; 2019 Apr; 3():1-20. PubMed ID: 30969799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the probability of random genetic mutations for various types of tumor growth.
    Tomasetti C
    Bull Math Biol; 2012 Jun; 74(6):1379-95. PubMed ID: 22311065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Mutations in Cancer Drug Resistance and Implications for Therapy.
    Beckman RA; Loeb LA
    Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584
    [No Abstract]   [Full Text] [Related]  

  • 10. Modeling multi-mutation and drug resistance: analysis of some case studies.
    Feizabadi MS
    Theor Biol Med Model; 2017 Mar; 14(1):6. PubMed ID: 28327183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cell density and mutations in a model of multidrug resistance in solid tumors.
    Greene J; Lavi O; Gottesman MM; Levy D
    Bull Math Biol; 2014 Mar; 76(3):627-53. PubMed ID: 24553772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance in cancer: principles of emergence and prevention.
    Komarova NL; Wodarz D
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9714-9. PubMed ID: 15980154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 14. Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.
    Cho H; Levy D
    Bull Math Biol; 2017 Dec; 79(12):2986-3012. PubMed ID: 29022203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance.
    Choi J; Park S; Ahn J
    Sci Rep; 2020 Feb; 10(1):1861. PubMed ID: 32024872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The worst drug rule revisited: mathematical modeling of cyclic cancer treatments.
    Katouli AA; Komarova NL
    Bull Math Biol; 2011 Mar; 73(3):549-84. PubMed ID: 20396972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cell density and intratumoral heterogeneity in multidrug resistance.
    Lavi O; Greene JM; Levy D; Gottesman MM
    Cancer Res; 2013 Dec; 73(24):7168-75. PubMed ID: 24163380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factors and drug resistance.
    Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
    Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach.
    Huang Y; Sadée W
    Drug Discov Today; 2003 Apr; 8(8):356-63. PubMed ID: 12681939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.